SEC Tracker
Get the app

Inovio Pharmaceuticals INO

Inovio Pharmaceuticals offers common stock and pre-funded warrants

Securities offering

Form
FWP
Filed
Importance
Routine
  1. Offers shares of common stock and pre-funded warrants to purchase shares
  2. Pre-funded warrants have an initial exercise price of $0.001 per share
  3. Net proceeds estimated at $ million for commercial launch and development
  4. Underwriters have option to purchase additional shares at public offering price

Written from the FWP on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Inovio Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Macrogenics MGNX public float $74M, Jun 30, 2025
  2. Volitionrx VNRX public float $73M, Jun 30, 2025
  3. Gyre Therapeutics GYRE public float $73M, Jun 30, 2025
  4. Oncolytics Biotech ONCY public float $72M, Jun 30, 2025
  5. Seres Therapeutics MCRB public float $72M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.